BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:39 AM | Browse: 574 | Download: 1308
 |
Received |
|
2020-07-25 07:25 |
|
Peer-Review Started |
|
2020-07-25 07:26 |
|
First Decision by Editorial Office Director |
|
2020-09-24 20:04 |
|
Return for Revision |
|
2020-09-24 20:04 |
|
Revised |
|
2020-09-30 04:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-10-19 08:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-10-20 03:41 |
|
Articles in Press |
|
2020-10-20 03:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-03 06:41 |
|
Publish the Manuscript Online |
|
2020-11-06 09:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Correction |
| Article Title |
Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, Kohei Shitara, Reo Sato, Tetsuo Akimoto and Takahiro Kinoshita |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Takeshi Kuwata, MD, PhD, Doctor, Doctor, Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, 6-5-1, Kashiwano-ha, Kashiwa 277-8577, Japan. tkuwata@east.ncc.go.jp |
| Key Words |
Correction; ; ; ; ; |
| Core Tip |
This manuscript is an author's affiliation correction for type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977) |
| Publish Date |
2020-11-06 09:07 |
| Citation |
Kaito A, Kuwata T, Tokunaga M, Shitara K, Sato R, Akimoto T, Kinoshita T. Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977). World J Clin Cases 2020; 8(21): 5494-5495
|
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i21/5494.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i21.5494 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
